2015 Celebration of Excellence - Medical, Scientific and Educational External Awards (2)

This document lists several internal awards given out, including the 10,000 Citation Award given to Jos Eggermont, and Citation Classic awards given to George Wyse, Todd Anderson, and Paul Beck for their influential published work. Teaching awards like the Killam Leadership in Teaching Award went to Sylvain Coderre, while the Killam Interdisciplinary Research Prize was given to Richard Frayne, Michael Smith, and Elise Fear. Research awards such as the Killam Research Leader Award and Killam Annual Professorship Award were presented to Cy Frank, V. Wee Yong, and Gerald Zamponi.

2013 celebrationofexcellencecs

2013 celebrationofexcellencemse

This document lists various medical, scientific, and educational external awards received by University of Alberta researchers, physicians, and research groups in 2012-2013. Some of the awards listed include the Alberta Health Service’s President’s Excellence Award, American Gastroenterological Association Research Mentor Award, American Institute of Ultrasound in Medicine Joseph H. Holmes Clinical Pioneer Award, Canadian Association of Gastroenterology Education Excellence Award, NASA Exceptional Engineering Achievement Medal, and The Lung Association (Alberta & NWT) Award of Excellence 2012.

2014 Celebration of Excellence - Distinguished Achievement and Medical, Scien...

2015 Celebration of Excellence - Medical, Scientific and Educational Extern...

2014 Celebration of Excellence - Community and Service Awards

2013 celebrationofexcellencedaa

Several physicians and researchers received prestigious awards and honors for their contributions to health sciences and medical research in Canada, including Brenda Hemmelgarn, Subrata Ghosh, and Todd Anderson who received Canadian Academy of Health Sciences Fellowships, and David Proud and Hans Vogel who received Royal Society of Canada Fellowships. Eldon Smith and Ian Lange received the Alberta Medical Association Medal for Distinguished Service.

In the last 6 years high-throughput screening has been used to identify FDA approved drugs that are active against multiple targets (also termed promiscuity). We have identified 34 studies that have screened libraries of FDA approved drugs against various whole cell or target assays. Each study has identified one or more compound with a new bioactivity that had not been previously described. Thirteen of these drugs were active against more than one additional disease, thereby suggesting a degree of promiscuity. The 109 molecules identified by screening in vitro were statistically more hydrophobic than orphan designated products with at least one marketing approval for a common disease indication or one marketing approval for a rare disease (FDA rare disease research database). We have created a database of in vitro data on old drugs for new uses that could be applied for repositioning these or other molecules for neglected and rare diseases.

Genetic and Engineering news Webinar slides

This document discusses repurposing existing drugs to treat rare diseases. It notes that over 7,000 rare diseases affect less than 200,000 people each, and many have no approved treatments. Screening existing drug libraries against disease targets in vitro has identified some drugs with potential new activities. Specifically, 13 drugs were found to be active against more than one additional disease. These promiscuous drugs tend to have properties similar to natural products and are more hydrophobic than other drugs identified from screening. The document advocates screening these promiscuous drugs first for new rare disease indications. It also describes databases of orphan drugs maintained by the FDA but notes they do not capture all high-throughput screening data that has been generated.

Celebration of Excellence 10th Anniversary event

The Cumming School of Medicine hosted the 10th anniversary edition of the Celebration of Excellence on February 28, 2018. Each year, the event celebrates faculty achievements in teaching and research ranging from early career awards and community honours, to the Order of Canada and Fellowships from the Royal Society of Canada and Canadian Academy of Health Sciences. Congratulations to those celebrated for awards received in 2017, and over the last decade.

Aua annouces 2011 award winners

The document announces the recipients of various awards from the American Urological Association (AUA) that will be presented at their upcoming annual meeting in May 2011. The awards recognize outstanding contributions to the field of urology by physician researchers and educators in areas such as genitourinary disease, incontinence, urological history, and service to the AUA. Several individuals were selected to receive awards for their significant work in areas like the pathophysiology of diseases, urological education, the integration of evidence-based guidelines, and lifetime dedication to advancing the field of endourology.

Aua annouces 2011 award winners

The document announces the recipients of various awards from the American Urological Association (AUA) that will be presented at their upcoming annual meeting in May 2011. The awards recognize outstanding contributions to the field of urology by physician researchers and educators in areas such as genitourinary disease, incontinence, urological history, and service to the AUA. Several individuals were selected to receive awards for their significant work in areas like bladder and prostate cancer, benign prostatic hyperplasia, urinary tract infections, and administrative leadership of the AUA.

Aua annouces 2011 award winners

The document announces the recipients of various awards from the American Urological Association (AUA) that will be presented at their upcoming annual meeting in May 2011. The awards recognize outstanding contributions to the field of urology by physician researchers and educators in areas such as genitourinary disease, incontinence, urological history, and service to the AUA. Several individuals were selected to receive awards for their significant work in areas like bladder and prostate cancer, benign prostatic hyperplasia, urinary tract infections, and administrative leadership of the AUA.

Acs finding promiscuous old drugs for new uses-final

The document discusses finding new uses for existing drugs through repurposing or repositioning old drugs. It notes that repurposing drugs can be more cost-effective than developing new drugs and can help address neglected and rare diseases. The document analyzes datasets of drugs identified in in vitro screens to have new biological activities and orphan drugs approved for rare diseases. It finds that drugs identified in screens tend to be more hydrophobic and higher weight than orphan drugs. It advocates for developing better curated databases of drug structures and properties to enable in silico screening for new uses. Overall, the document makes the case that repurposing existing drugs is a promising strategy to develop new treatments, especially for rare and neglected diseases, and that informatics

Indications discovery and drug repurposing

The document discusses using collaborative drug discovery software and databases to facilitate drug repositioning efforts for rare and neglected diseases. It provides an example of how the Collaborative Drug Discovery platform was used to share data and enable screening partnerships between multiple academic and industry groups working on tuberculosis. The document also summarizes research that identified over 100 molecules by screening approved drugs for new activities in vitro, finding some drugs with potential activity against multiple diseases. This highlights opportunities for drug repositioning but challenges of data sharing that collaborative platforms could help address.

Essentials of clinical examination handbook 7 e (2013)[pdf][koudiai] vrg

libaan hassan

essential clinical examination Table of Contents The General History and Physical Exam 1 The Abdominal Exam 17 The Breast Exam 37 The Cardiovascular Exam 49 The Geriatric Exam 69 The Gynecological Exam 79 The Head and Neck Exam 97 The Lymphatic System and Lymph Node Exam 123 The Musculoskeletal Exam 133 The Neurological Exam 171 The Obstetric Exam 207 The Ophthalmological Exam 229 The Pediatric Exam 249 The Peripheral Vascular Exam 295 The Psychiatric Exam 317 The Respiratory Exam 347 The Urological Exam 363 The Essentials of Clinical Pharmacology and Toxicology 379 The Essentials of Dermatology 395 The Essentials of Emergency Medicine 421 The Essentials of Endocrinology 441 The Essentials of Fluids, Electrolytes, and Acid/Base Disturbances 455 The Essentials of General Surgery 473 The Essentials of Infectious Diseases 485 The Essentials of Medical Imaging 511 The Essentials of Oncology 549 The Essentials of Pain Management and Pre-Operative Assessment 559 Appendix 1: Concepts in Evidence-Informed Medical Practice 571 Appendix 2: Commonly Used Drugs 585 Appendix 3: Common Laboratory Values 601 Index 613

3. Organ and Tissue Donation

Rotary International

Transplantation of human tissues and organs is an important lifesaving medical procedure. You’ll hear personal stories from both donors and recipients as well as facts from international medical authorities and learn about organ and tissue donation registries around the world. Make a commitment to become a donor, and learn how you can inspire others in your club and community to do the same. Attendees will also enjoy a short performance from opera singer and transplant recipient Hae-Chul Lim and a small group of guest vocalists.

Intensive Care Professionals and their role in Organ Donation

Stiftelsen Organdonasjon

Simon Conroy EMRAN Launch

CCraig138

This document discusses the need for research into aging to improve patient care and test interventions for older populations. It notes that older adults have historically been excluded from clinical trials due to ageism and practical barriers. This can lead to a lack of evidence about treatments for older patient groups. It then outlines existing support for aging research from organizations like the UK Clinical Research Network and its East Midlands division. Finally, it proposes possible roles for an East Midlands Research into Aging Network in coordinating aging research efforts through navigation, connection, peer support, and maintaining institutional memory.

Open letter the statistical analysis and data integrity of mehra et al final

ilfattoquotidiano.it

This open letter, signed by over 100 clinicians, researchers, and ethicists from around the world, expresses concerns about the validity and integrity of data from a large observational study published in The Lancet on the use of hydroxychloroquine and chloroquine for COVID-19. Specifically, the letter raises doubts about the source of the data, a lack of peer review and independent validation, implausible findings, and lack of transparency from the authors and The Lancet. It calls for independent analysis of the data and transparency from the authors and journal.

Viewers also liked

2015 Celebration of Excellence - Community, Service, Citation and University ...

2014 Celebration of Excellence - Citation and Internal Awards

2015 Celebration of Excellence - Distinguished Achievement Awards

2014 Celebration of Excellence

2017 Celebration of Excellence

2015 Celebration of Excellence

2016 Celebration of Excellence

2013 Celebration of Excellence

Viewers also liked (8)

2015 Celebration of Excellence - Community, Service, Citation and University ...

2014 Celebration of Excellence - Citation and Internal Awards

2015 Celebration of Excellence - Distinguished Achievement Awards

2014 Celebration of Excellence

2017 Celebration of Excellence

2015 Celebration of Excellence

2016 Celebration of Excellence

2013 Celebration of Excellence

Similar to 2015 Celebration of Excellence - Medical, Scientific and Educational External Awards (2)

11th Annual Celebration of Excellence - February 27, 2019

US Environmental Protection Agency (EPA), Center for Computational Toxicology and Exposure

Finding promiscuous old drugs for new uses

Genetic and Engineering news Webinar slides

Celebration of Excellence 10th Anniversary event

Aua annouces 2011 award winners

Aua annouces 2011 award winners

The document announces the recipients of various awards from the American Urological Association (AUA) that will be presented at their upcoming annual meeting in May 2011. The awards recognize outstanding contributions to the field of urology by physician researchers and educators in areas such as genitourinary disease, incontinence, urological history, and service to the AUA. Several individuals were selected to receive awards for their significant work in areas like bladder and prostate cancer, benign prostatic hyperplasia, urinary tract infections, and administrative leadership of the AUA.

Aua annouces 2011 award winners

The document announces the recipients of various awards from the American Urological Association (AUA) that will be presented at their upcoming annual meeting in May 2011. The awards recognize outstanding contributions to the field of urology by physician researchers and educators in areas such as genitourinary disease, incontinence, urological history, and service to the AUA. Several individuals were selected to receive awards for their significant work in areas like bladder and prostate cancer, benign prostatic hyperplasia, urinary tract infections, and administrative leadership of the AUA.

Acs finding promiscuous old drugs for new uses-final

Indications discovery and drug repurposing